Results of Annual General Meeting Sydney, 17 November 2026: Clinical-stage biotech company Noxopharm Limited (ASX:NOX) is pleased to announce the results of today’s Annual General Meeting. The results are set out in the attached document, in accordance with ASX Listing Rule 3.13.2 and Section...
Results of Meeting
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Noxopharm Ltd. has announced the results of its Annual General Meeting, confirming that all resolutions were passed by poll. The resolution regarding the adoption of the remuneration report received significant support, with a majority voting in favor.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Earlier from Noxopharm
- Noxopharm 2026 AGM Corporate Presentation
- Noxopharm 2026 AGM Chair's Address
- Noxopharm receives $1.4 million R&D tax incentive rebate
- Noxopharm Investor Webinar
- Cleansing Statement
Later from Noxopharm
All Noxopharm news releasesFollow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm